87 related articles for article (PubMed ID: 18845909)
1. A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets.
Hayata K; Nakayama T; Matsushita T; Sakano K
J Pharmacol Sci; 2008 Oct; 108(2):217-21. PubMed ID: 18845909
[TBL] [Abstract][Full Text] [Related]
2. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
Phillips MD; Moake JL; Nolasco L; Turner N
Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
[TBL] [Abstract][Full Text] [Related]
3. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
5. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y
J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
[TBL] [Abstract][Full Text] [Related]
6. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
[TBL] [Abstract][Full Text] [Related]
7. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
8. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
[TBL] [Abstract][Full Text] [Related]
9. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
10. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
Boncler MA; Golanski J; Paczuski R; Watala C
J Mol Med (Berl); 2002 Dec; 80(12):796-801. PubMed ID: 12483465
[TBL] [Abstract][Full Text] [Related]
12. Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond.
Nakayama T; Matsushita T; Dong Z; Sadler JE; Jorieux S; Mazurier C; Meyer D; Kojima T; Saito H
J Biol Chem; 2002 Jun; 277(24):22063-72. PubMed ID: 11943773
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
14. Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
Patzke J; Favaloro EJ
Methods Mol Biol; 2017; 1646():453-460. PubMed ID: 28804847
[TBL] [Abstract][Full Text] [Related]
15. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
[TBL] [Abstract][Full Text] [Related]
16. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
Kang M; Wilson L; Kermode JC
Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
[TBL] [Abstract][Full Text] [Related]
17. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
Weinstein M; Vosburgh E; Phillips M; Turner N; Chute-Rose L; Moake J
Blood; 1991 Nov; 78(9):2291-8. PubMed ID: 1932745
[TBL] [Abstract][Full Text] [Related]
18. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex.
Bradford HN; Dela Cadena RA; Kunapuli SP; Dong JF; Löpez JA; Colman RW
Blood; 1997 Aug; 90(4):1508-15. PubMed ID: 9269768
[TBL] [Abstract][Full Text] [Related]
19. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
O'Brien JR; Etherington MD
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
Chang MC; Lin HK; Peng HC; Huang TF
Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]